Form D · Venture Capital Fund

FRx Select I, LP

New York, NY · CIK 0001750904

Offering snapshot reported Nov 8, 2018 · SEC filing

Reported sold
Yet to sell
Offering amount: $25M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 8, 2018InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-325423

Source: Form D, filed Nov 8, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

FRX SELECT I, LP

Investment adviser: MBX CAPITAL, LLC

Gross asset value
$13.5M
Beneficial owners
73
ADV minimum commitment
$4.55K

Reported in Form ADV on Mar 9, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ADURO ADVISORS, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor SENSIBA SAN FILIPPO SAN FRANCISCO, California, United States
Custodian CHOICE FINANCIAL GROUP VIRGINIA BEACH, Virginia, United States Related to adviser: No
Marketer BTIG, LLC SAN FRANCISCO, California, United States Related to adviser: No
Prime broker RAYMOND JAMES & ASSOCIATES, INC. ST. PETERSBURG, Florida, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

BTIG, LLC
CRD 122225 · SEC 8-65473

RAYMOND JAMES & ASSOCIATES, INC.
CRD 705 · SEC 8-10999

Filing source

Form ADV 2065550 · Mar 9, 2026 · Schedule D 7.B.(1), fund 805-2099384530

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gurdane Bhutani Director
N/A Fund Rx Capital Management, Llc Director
N/A Fund Rx Capital Partners, Llc Director
N/A Fund Rx, Inc. Director
Zeshan Muhammedi Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
71 Broadway, Level 2 B #102
New York, NY, 10006